Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Clasificación en acciones #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Precio por acción
$2.35
Última sincronización: 2022-09-07
Capitalización bursátil
$162.94K
Cambio (1 día)
2.17%
Cambio (1 año)
0.00%
País
US
Comercio Brickell Biotech, Inc. (BBI)

Categoría

Precio BBI con Capital del mercado a B
Brickell Biotech, Inc. Brickell Biotech, Inc.
BBI
$2.35
Capitalización de mercado de Brickell Biotech, Inc.(BBI)
Capitalización bursátil: $162.94K
A fecha de August 2026, Brickell Biotech, Inc. tiene una capitalización de mercado de $162.94K. Esto convierte a Brickell Biotech, Inc. en la 40377th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Brickell Biotech, Inc. desde 2019 hasta 2026
BBI en comparación con los más populares 5 títulos stocks
Precio por BBI Activo B Capital del mercado en B Resultados
Brickell Biotech, Inc. Brickell Biotech, Inc.
$78,884,530 $162.94K
$5.470T +3,356,788,414.27%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$64,426,434 $162.94K
$4.467T +2,741,550,267.91%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$60,205,180 $162.94K
$4.174T +2,561,922,456.83%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$53,364,447 $162.94K
$3.700T +2,270,827,439.47%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$41,166,821 $162.94K
$2.854T +1,751,779,516.19%